These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 12107643

  • 1. Synthesis of a palladium(II)-dithiocarbamate complex: biological assay and nephrotoxicity in rats.
    Trevisan A, Marzano C, Cristofori P, Borella Venturini M, Giovagnini L, Fregona D.
    Arch Toxicol; 2002 Jun; 76(5-6):262-8. PubMed ID: 12107643
    [Abstract] [Full Text] [Related]

  • 2. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C, Bettio F, Baccichetti F, Trevisan A, Giovagnini L, Fregona D.
    Chem Biol Interact; 2004 Jun 30; 148(1-2):37-48. PubMed ID: 15223355
    [Abstract] [Full Text] [Related]

  • 3. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
    Ronconi L, Giovagnini L, Marzano C, Bettìo F, Graziani R, Pilloni G, Fregona D.
    Inorg Chem; 2005 Mar 21; 44(6):1867-81. PubMed ID: 15762713
    [Abstract] [Full Text] [Related]

  • 4. Characterization studies and cytotoxicity assays of Pt(II) and Pd(II) dithiocarbamate complexes by means of FT-IR, NMR spectroscopy and mass spectrometry.
    Alverdi V, Giovagnini L, Marzano C, Seraglia R, Bettio F, Sitran S, Graziani R, Fregona D.
    J Inorg Biochem; 2004 Jun 21; 98(6):1117-28. PubMed ID: 15149823
    [Abstract] [Full Text] [Related]

  • 5. Mixed complexes of Pt(II) and Pd(II) with ethylsarcosinedithiocarbamate and 2-/3-picoline as antitumor agents.
    Giovagnini L, Marzano C, Bettio F, Fregona D.
    J Inorg Biochem; 2005 Nov 21; 99(11):2139-50. PubMed ID: 16165215
    [Abstract] [Full Text] [Related]

  • 6. In vitro antitumor activity of 2-acetyl pyridine 4n-ethyl thiosemicarbazone and its platinum(II) and palladium(II) complexes.
    Kovala-Demertzi D, Boccarelli A, Demertzis MA, Coluccia M.
    Chemotherapy; 2007 Nov 21; 53(2):148-52. PubMed ID: 17308381
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes.
    Giovagnini L, Ronconi L, Aldinucci D, Lorenzon D, Sitran S, Fregona D.
    J Med Chem; 2005 Mar 10; 48(5):1588-95. PubMed ID: 15743200
    [Abstract] [Full Text] [Related]

  • 8. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC, Bacac M, Velders AH, Jansen BA, Kooijman H, Spek AL, Haasnoot JG, Reedijk J.
    J Med Chem; 2003 Apr 24; 46(9):1743-50. PubMed ID: 12699392
    [Abstract] [Full Text] [Related]

  • 9. [In vitro biological activity of new platinum(II) and palladium(II) complex compounds].
    Malinowska K, Modranka R, Kubiak K, Mrowicka M, Kedziora J, Klimczak A, Rutkowski M.
    Pol Merkur Lekarski; 2009 Jan 24; 26(151):52-6. PubMed ID: 19391508
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C, Pellei M, Colavito D, Alidori S, Lobbia GG, Gandin V, Tisato F, Santini C.
    J Med Chem; 2006 Dec 14; 49(25):7317-24. PubMed ID: 17149861
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxic and proapoptotic effects of new Pd(II) and Pt(II)-complexes with 3-ethanimidoyl-2-methoxy-2H-1,2-benzoxaphosphinin-4-ol-2-oxide.
    Budzisz E, Krajewska U, Rózalski M.
    Pol J Pharmacol; 2004 Dec 14; 56(4):473-8. PubMed ID: 15520503
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, characterization and in vitro cytotoxicity of the first palladium(II) oxalato complexes involving adenine-based ligands.
    Starha P, Trávnícek Z, Popa I.
    J Inorg Biochem; 2009 Jul 14; 103(7):978-88. PubMed ID: 19457557
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxic activity of some gold(III) complexes.
    Cossu F, Matovic Z, Radanovic D, Ponticelli G.
    Farmaco; 1994 Apr 14; 49(4):301-2. PubMed ID: 8049012
    [Abstract] [Full Text] [Related]

  • 14. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
    Kim WK, Kwon YE.
    Cancer Chemother Pharmacol; 2007 Jul 14; 60(2):237-43. PubMed ID: 17089165
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and characterization of a novel Pd(II) complex with the condensation product of 2-(diphenylphosphino)benzaldehyde and ethyl hydrazinoacetate. Cytotoxic activity of the synthesized complex and related Pd(II) and Pt(II) complexes.
    Malesević N, Srdić T, Radulović S, Sladić D, Radulović V, Brceski I, Andelković K.
    J Inorg Biochem; 2006 Nov 14; 100(11):1811-8. PubMed ID: 16938348
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, characterization and anticancer studies of mixed ligand dithiocarbamate palladium(II) complexes.
    Khan H, Badshah A, Murtaz G, Said M, Rehman ZU, Neuhausen C, Todorova M, Jean-Claude BJ, Butler IS.
    Eur J Med Chem; 2011 Sep 14; 46(9):4071-7. PubMed ID: 21724304
    [Abstract] [Full Text] [Related]

  • 17. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S, Kalayda GV, Lutz M, Spek AL, Yamanaka Y, Sato T, Chikuma M, Reedijk J.
    J Med Chem; 2003 Mar 27; 46(7):1210-9. PubMed ID: 12646031
    [Abstract] [Full Text] [Related]

  • 18. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties.
    Ronconi L, Marzano C, Zanello P, Corsini M, Miolo G, Maccà C, Trevisan A, Fregona D.
    J Med Chem; 2006 Mar 09; 49(5):1648-57. PubMed ID: 16509581
    [Abstract] [Full Text] [Related]

  • 19. Preliminary fluorimetric screening of fourteen palladium complexes as potential antitumor agents.
    Lin HX, Li ZL, Dai GL, Bi QS, Yu RQ.
    Sci China B; 1993 Oct 09; 36(10):1216-23. PubMed ID: 8136034
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs.
    Urquiola C, Vieites M, Torre MH, Cabrera M, Lavaggi ML, Cerecetto H, González M, Cerain AL, Monge A, Smircich P, Garat B, Gambino D.
    Bioorg Med Chem; 2009 Feb 15; 17(4):1623-9. PubMed ID: 19162490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.